Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine Note: the FDA considers body composition metrics to be safety endpoints which often results in underpowered secondary endpoints in Phase 3 registration trials
Spicer JD, Shewale JB, Bott MJ, Jones DR, Vaporciyan AA, Darling GE, Swisher SG , Sepesi B
Most chronic diseases are related to oxidative stress arising from the affected tissue losing the capacity to maintain glutathione at adequate healthy levels
The authors analyzed data from studies in which researchers measured glutathione levels in the brains (eight studies) or blood (33 studies) of people with Alzheimers disease or mild cognitive impairment and compared those levels to healthy people
As with other substance use disorders, both genetic (such as mutations in the opioid receptor gene (10)) and environmental factors (such as exposure to trauma), contribute to the risk of developing opioid use disorder.(11) Ready access to prescription opioid, heroin, and fentanyl have all contributed to the current opioid epidemic
If you are experiencing a bad taste in your mouth whilst taking Mounjaro, several practical strategies may help alleviate this symptom and improve your comfort during treatment
